OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-12-31-accounts

British Society of Gastroenterology

Annual Report and Financial Statements

December 2024

Charity Registration Number 1149074

Company Limited by Guarantee

Registration Number 08124892 (England & Wales)

British Society of Gastroenterology 1

Introduction......................................................................................................................................3
Reference and administrative details of the Society, its Trustees and advisers ................4
Report from the BSG Chair of the Trustees......................................................................................6
Our Purpose......................................................................................................................................6
Charitable Objects ......................................................................................................................... 6
Our Activities and Achievements.....................................................................................................8
Membership .................................................................................................................................. 8
Project 90 ...................................................................................................................................... 8
Recognising our Members ............................................................................................................. 9
BSG Events ..................................................................................................................................... 9
Education and Training................................................................................................................10
Clinical Services and Standards ................................................................................................... 11
Research ...................................................................................................................................... 12
International Engagement...........................................................................................................13
The 2024 European Specialty Examination in Gastroenterology and Hepatology......................13
Climate Change and Sustainability .............................................................................................. 14
Our Journals ................................................................................................................................ 14
Future activities
2025 .........................................................................................................15
Our Structure and Governance......................................................................................................16
Our Structure ............................................................................................................................... 16
Operational
.........................................................................................................................20
Fundraising .................................................................................................................................. 20
Organisational Governance Achievements..................................................................................20
Equality, Diversity and Inclusion .................................................................................................. 20
Risk Management ....................................................................................................................... 21
Financial report for the year...........................................................................................................22

British Society of Gastroenterology 2

Introduction

The British Society of Gastroenterology continues to thrive as an organisation with the highest membership in our history and record attendance at BSG LIVE in 2024. The Society is truly multidisciplinary, with members from medical, nursing and allied health professional backgrounds. We incorporated medical undergraduates at the end of 2022, and this group has continued to grow and contribute. This diversity of membership categories and levels of experience ts well with our Equality, Diversity and Inclusion (EDI) strategy and will help improve any disparities with time. We are publishing detailed EDI metrics on the committees and activities of the BSG in a fully transparent manner, and will performance manage ourselves against the key performance indicators in the EDI strategy.

Environmental sustainability continues to be a key consideration which extends to our external activities and relationships with partner organisations and industry.

The BSG strategy, published in July 2024, is being delivered to an excellent standard by our sections and committees. We continue to be impressed by the high standard of guidelines, education, managed. We are grateful to all those who give their time to BSG and are particularly grateful to the lay trustees who provide invaluable advice to the BSG.

We have delivered a major upgrade to our website and IT capabilities which have delivered an improved experience for the board. Plans are underway to greatly -year project all our members to help them get inspired by their profession and by gastroenterology, and we are excited to see it taking shape.

We recognise that our success is down to our members, volunteers, patients, external stakeholders and team, and thank you all for your contributions to making the BSG the success it has been in 2024.

BSG President, Professor Colin Rees

BSG CEO, Mrs Sarah Linnington

British Society of Gastroenterology 3

Reference and administrative details of the Society, its Trustees and advisers

Trustees Ms M Azdejkovic Dr U Basavaraju Prof P Bhandari (appointed 21 June 2024) Mr T Budd Dr M Cowan (appointed 21 June 2024) Ms J Flitcroft Dr H Gordon (appointed 21 June 2024) Dr C Hollywood Mr T Jones Mrs R Lloyd Mr P McCauley Dr J Morris Dr B Oates (resigned 21 June 2024) Prof C Rees Prof H Steed Prof D Tripathi (resigned 21 June 2024) Prof A Veitch (resigned 21 June 2024) Chief Executive Mrs S Linnington Registered/Principal 3 St Andrews Place London NW1 4LB Telephone 020 7935 3150 E-mail president@bsg.org.uk website www.bsg.org.uk Charity Registration Number 1149074 Company Registration Number 08124892 (England and Wales)

British Society of Gastroenterology 4

Auditor Moore Kingston Smith LLP 6[th] Floor 9 Appold Street London EC2A 2AP Solicitors Druces LLP Salisbury House London Wall London EC2M 5PS Bankers National Westminster Bank Plc PO Box 2021 10 Marylebone High Street London W1A 2AS Investment Managers CCLA Senator House 85 Queen Victoria Street London EC4V 4ET

British Society of Gastroenterology 5

Report from the BSG Chair of the Trustees

company BSG Limited (together the or for the year ended 31 December 2024.

This report has been prepared in accordance with Part 8 of the Charities Act 2011 and constitutes a report for the purposes of company legislation.

on pages 33 to 36 of the attached nancial Memorandum and Articles of Association, applicable laws and Accounting and Reporting by statements in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102).

Professor Colin Rees

BSG President & Chair of Board of Trustees June 2024 to June 2026

Our Purpose

The purpose of the Society is the promotion of good health through high standards of patient care, clinical service provision, research and education in gastrointestinal and liver disease in the United Kingdom and internationally.

Charitable Objects

The BSG primarily pursues its charitable objects by supporting members in their professional capacities. This purpose is achieved through a series of workstreams related to the charitable objects of research, education and training, clinical standards and membership support.

Research

To promote the discovery and dissemination of knowledge by:

Holding regular presentations of research ndings.

British Society of Gastroenterology 6

Clinical Standards

To promote high-quality patient care and the

of best practice by:

Education

To promote this object by:

Membership and Workforce

To provide support to the professional community by connecting members through active networking, the dissemination of information and supporting their lifelong professional development and learning by:

Promoting equality and diversity in our workforce and leadership.

British Society of Gastroenterology 7

Our Activities and Achievements

Membership

In December 2024, our total members across categories were as follows:

2024
No.
2023
No.
Honorary
Full
International
Trainee
Senior
Associate
Taster
Undergraduate		 97
98
1604
1614
112
104
724
692
92
89
970
882
563
537
96
11
4,258
4,027

In 2024, we celebrated record membership numbers, with a total of 4,258 members, which is a associate membership categories (comprising Nurses, GI Physiologists and Allied Health Professionals), as well as our undergraduate category, which was launched in 2022 to give medical, nursing and students the opportunity to join the BSG free of charge and gain access to BSG events and opportunities to apply for bursaries.

Project 90

because of service pressures, workforce shortages and long patient waiting lists. Many of these opportunities to celebrate the profession and the membership by providing enhanced membership support with the overarching aim of allowing members to discover or re-discover their passion for align this three-

In March 2024, the BSG Executive and the Board of Trustees approved a substantial budget for this work and appointed a Project Lead. Since then, we have set up a Project 90 Steering Group with workstream leads in the following areas:

British Society of Gastroenterology 8

The remainder of the year saw work progress with project plans for each workstream, several initiatives out to commercial tender and further exploration of what might be achievable.

Recognising our Members

The BSG runs a substantial awards programme that recognises the achievements of members across the Society. These include:

BSG Events

BSG LIVE

conference organisers, TFI Lodestar. With over 2,400 attendees, the event was a huge success, and for the rst time in our history, we sold out. The atmosphere was fantastic, with great feedback from delegates expanded to run seven consecutive streams of symposia and 1,000 delegates watching at least one session on-demand.

BSG Campus

In December 2024, we delivered an online conference, BSG Campus, with a studio in the BSG which enabled live interaction between speakers and the panels. There were over 600 registrations for this event, and it had positive feedback.

Trainee Events

British Society of Gastroenterology 9

Other In-Person Events

Webinars

Education and Training

Web Education

The BSG Web Education team published nine videos, ten articles and a journal highlight covering a variety of topics which have been viewed by over 25,000 people in 2024.

Travel Bursaries for the BSG Annual Meeting

We awarded BSG travel bursaries to fourteen trainees, ve nurses and thirteen undergraduates who would have otherwise struggled nancially to attend the BSG Annual Meeting.

British Society of Gastroenterology 10

Endorsement of External Events

We were proud to give BSG event endorsement to twenty external events and courses in 2024 that educational value to our members.

Mentoring Programme

Our core mentoring programme has continued to grow and in 2024 100 mentees from 70 mentors. In July 2024, we launched an additional programme intended to provide short term mentoring around the application and interview process for IMT members who are applying to gain a National Training Number in Gastroenterology and so grow the workforce. We were pleased that the rst year saw twelve mentees take advantage of the mentoring scheme.

Supporting Training

The BSG Training Committee has been focused on supporting the implementation of the 2022 curriculum for Higher Specialty Training. The reduction in the training time associated with the new curriculum remains a concern for us all, as does reconciling the demands of both General Internal Medicine (GIM) (especially contributing to the acute unselected take) and gastroenterology training. In collaboration with the gastroenterology Specialist Advisory Committee (SAC) and the BSG Trainees Section, the Training Committee has been proactive in monitoring the progression of trainees and will provide ongoing support. To address training challenges, a Training Concerns Short-Life Working Group has been established, providing access to key documents, which have informed the agendas of the SAC and BSG Training Committee. The group is also working towards the development of gastroenterology training quality indicators to improve training standards.

Working with Primary Care

The Training Committee collaborated with the Primary Care Society of Gastroenterology to produce a Training Framework for General Practitioners with Extended Roles in Gastroenterology, to provide guidance to support colleagues in primary care.

Clinical Services and Standards

Key Publications

We have published several highguidelines including:

BSG guidelines for the management of iron deficiency anaemia in adults

Following NICE's decision to end its formal accreditation process, our guidelines process has undergone a strategic review. The Clinical Services and Standards Committee (CSSC) remains committed to maintaining robust methodology standards, supported by the future recruitment of a dedicated guideline training lead.

Workforce

The anticipated Annual Workforce Report has been completed and is pending imminent publication, providing crucial insights into gastroenterology workforce needs and challenges.

British Society of Gastroenterology 11

Quality Improvement (QI)

Several initiatives are being revitalised through a comprehensive strategic review, with plans to establish QI fellowships. Development of a service hub for clinical resources is progressing, while strengthened regional representation networks enhance engagement and implementation of BSG initiatives across regions.

National Voice

The CSSC actively contributes to national healthcare initiatives, including GIRFT and the NHS tenyear plan. Work is ongoing to update the BSG job planning guidance document, evolving service needs and workforce patterns. Many parts of BSG engage regularly with NHSE and other stakeholders in England and the other nations of BSG.

Research

BSG Research Scholars Scheme

The new scheme has been instrumental to overcoming some of the barriers that clinicians face active clinicians and allied health professionals to carve out time to dedicate to pursuing research. We currently have six scholars spanning diverse research areas and disciplines.

NIHR Associate Principal Investigator Scheme

We have supported many BSG trainees in joining this scheme that will train our clinical research leaders of the future. This has been bolstered by the incredibly productive Trainee Research Networks who continue to tackle some of the key clinical research questions.

Partnership with the Birmingham Centre for Observational and Prospective Studies (BiCOPS)

Through this partnership, we can provide project support to BSG member researchers using the REDCap (Research Electronic Data Capture) system over the next three years. To date BiCOPS have been supporting the trainee-led project SABRE-IBD study and most recently a study -ED CRC).

Priority Setting Partnerships (PSPs)

Through engagement with the James Lind Alliance, our Clinical Research Groups (CRGs) have been progressing with three completed/near completed PSPs in IBS, Pancreatitis and Diverticular Disease. The Pancreas CRG has been particularly active in 2024 and following the publication of the Pancreatitis PSP in the Lancet Gastroenterology and Hepatology in late 2023 delivered a successful years and pump primed four new projects.

The Gut Microbiota for Health Expert Panel (GMfH)

The GMfH have held twice yearly virtual meetings in addition to responding to increasing promotion and information requests on gut microbiome testing and faecal microbiota transplantation.

British Society of Gastroenterology 12

International Engagement

International Grand Rounds

The second season of these launched in 2024, featuring expert speakers from over twenty regions and countries sharing their expertise in topics based around the curriculum of RCP Specialty examinations. As well as being featured on the BSG website, it has also gained more visibility via inclusion on the WGO education and training portal.

International Grants

There were seven grants awarded in 2023 and bowel cancer screening, and all of these were either completed or nearing completion by the close of 2024, with summary reports available here. A new round of grant applications was opened in late 2024, and we look forward to seeing the impact of these on GI and liver healthcare across the globe.

Improving Endoscopy Reporting

We also funded a further project which was completed in 2024 that achieved a milestone in standardisation and improvement of endoscopy reporting in Nigeria and Zambia. A project report is available on the BSG website.

Collaboration through Memorandums of Understanding (MOUs)

The committee is committed to consolidating and expanding collaborations with other international organisations. We are strengthening the existing MOUs with China and Bangladesh and are in advanced discussions with the Indian Society of Gastroenterology (ISG). We are also in discussions with GESA (Gastroenterology Society of Australia) and it is anticipated that an MOU will come to fruition in 2025. A strategy for international collaboration was agreed.

Engaging Trainee and Nurse Members

Trainee and Nurse International Membership options were introduced in February 2024 and are being well promoted. Since then, our international membership has gradually grown, and we now have more than 100 members.

The 2024 European Specialty Examination in Gastroenterology and Hepatology (ESEGH)

The examination consisted of two sessions of three hours. During each session candidates answered 100 best-ofquestions, which were displayed in a random order. A total of 608 candidates completed both sessions, 217 from the UK.

For this examination, 72 questions were new i.e. they had not been pre-tested or used before, and 128 items were re-used from previous diets.

British Society of Gastroenterology 13

performance after excluding OTH trainees. The equated pass mark for 2024 was set at 432 (63.6%). This resulted in a pass rate for all candidates of 53.3%, which has dropped slightly from 54.7% in 2023. For UK trainees, the pass rate was 62.7%, which has increased from 61.5% in 2023. For European centres (UK excluded) the pass rate was 64.9% (up from 64.4%).

Climate Change and Sustainability

The BSG Annual Conference

During the early months of 2024, we collaborated with our event partners, TFI Lodestar to embed sustainability as a core principle of BSG LIVE. Attendees were encouraged to travel sustainably, and international speakers were only invited if they accepted multiple roles in the programme. We formed a new partnership with Event Cycle, where the surplus materials were transformed into positive social and environmental outcomes by repurposing graphics, foamex boards and toys from the event. Finally, we ensured a solely vegetarian choice of catering options on two days of the conference.

Collaboration

We have partnered with the Centre for Sustainable Healthcare (CSH) to develop training modules for in sustainable gastroenterology. Content was nalised in 2024 and is now with a developer to build. We have also worked with multiple organisations, including the UK Health Alliance on Climate Change (UKHACC), to lobby for a sustainability commitment across the health and social care sector.

Carbon Footprint Reporting

We also looked inwardly, as well as outwardly, to calculate the carbon footprint of the organisation sustainable operations. This involved a detailed interrogation of our accounts, and the interviewing This report was published on the BSG website in April 2025.

Our Journals

We are proud to co-own three gastroenterology journals with the BMJ, and access to these journals paper journals, the BMJ launched an e-version of both Gut and Frontline Gastroenterology in an exclusive interactive format for BSG members, which has had positive feedback.

Gut

First published in 1960, Gut gastroenterology. It publishes high impact research and review papers, complemented by guidelines, commentaries and educational content. It has an impact factor of 23.1 and is ranked 5th of 143 journals in its Science Citation Index category.

British Society of Gastroenterology 14

Frontline Gastroenterology (FG)

Frontline Gastroenterology continues to publish high quality education and practice papers as well as selected original research to support the needs of clinicians and allied professionals working in gastroenterology, hepatology and clinical nutrition. The journal has an impact factor of 2.6 in 2023, alongside a CiteScore of 4.7. At the end of 2024, Prof Mark Beattie stepped down as Editor-in-Chief after almost six years. We thank him for his leadership, and welcome new Editor-in-Chief Dr Phil Smith.

BMJ Open Gastroenterology (BMJOG)

Open Gastroenterology publishes quality papers across the breadth of gastroenterology, including hepatology, nutrition and endoscopy. As an open access journal, all content is free to download, read and share without restriction, ensuring the widest possible dissemination. BSG members benefit from a 30% discount on the article processing charge. Open Gastroenterology has an impact factor of 3.3 and a CiteScore of 5.9.

Future activities 2025

Supporting our members

Education and Events

We will continue to deliver high-quality education for our members.

British Society of Gastroenterology 15

Clinical Services and Standards

Research

where research has fallen to the bottom of their agenda post COVID-19.

International

Our Structure and Governance

The British Society of Gastroenterology is a charitable company limited by guarantee (Company Number 08124892 (England and Wales), Charity Number 1149074). The Memorandum and Articles

The charity controls the subsidiary entity, BSG Limited (Company Number 3021266) (England and Wales).

Our Structure

Board of Trustees

The business of the Charity is managed by the Board of Trustees subject to the provisions of the Companies Act, Charities Act and the Society's Rules. The Board of Trustees consists of six

No Trustee received any remuneration for services as a member of the Board. Eleven Trustees were reimbursed expenses totalling £11,421 (2023 - twelve Trustees received expenses totalling £8,383). All expenses were incurred on Society business. No contract with the Society whilst serving on the Board.

British Society of Gastroenterology 16

New Trustees receive an induction pack. This includes the BSG's Memorandum and Articles, last responsibilities of charity Trustees, and a copy of the Good Trustee Guide, published by the National Council of Voluntary Organisations, for their reference. Trustees are also required to attend training sessions on various topics relevant to Trustees' duties and responsibilities. The Trustees met twice face to face, and twice remotely in 2024.

Members of the Board of Trustees

Ms M Azdejkovic (Independent Lay Trustee) Dr U Basavaraju (BSG Elected Councillor) Prof P Bhandari (appointed 21 June 2024) (Vice President Endoscopy 2024-2026) Mr T Budd (Independent Lay Trustee) Dr M Cowan (appointed 21 June 2024) (BSG Elected Councillor) Dr H Gordon (appointed 21 June 2024) (President Elect 2024-2026) Ms J Flitcroft (Independent Lay Trustee) Dr C Hollywood (Vice President Hepatology 2023-2025) Mr T Jones (Independent Lay Trustee) Mrs R Lloyd (Independent Lay Trustee) Mr P McCauley (Independent Lay Trustee) Dr J Morris (Treasurer 2024-2026) Dr B Oates (resigned 21 June 2024) (Treasurer 2022-2024) Prof C Rees (President 2024-2026) Prof H Steed (Senior Secretary 2023-2025) Prof D Tripathi (resigned 21 June 2024) (BSG Elected Councillor) Prof A Veitch (resigned 21 June 2024) (President 2022-2024)

The Executive Committee

The Executive is responsible for overseeing the day to day running of the Society supported by the interview, chaired by a lay member of the Board of Trustees and hold delegated authority from the Trustees. This is

The BSG President serves two years, having previously served two years as President Elect. The current President, Prof Colin Rees will serve until June 2026, when he will be succeeded by the current President-Elect Dr Harriet Gordon. The Vice President (Endoscopy) and the Vice President (Hepatology) currently serve for two years as Deputy and then two years as VP. The Secretaries of the Society serve for two years as Secretary and then two years as Senior Secretary. The Treasurer serves for two years with the option to extend for a further year, and the Chairs of the Education, Research, Training, CSSC and International Committees serve for two years as Deputy and two years as Chair.

British Society of Gastroenterology 17

Members of the Executive

Prof C Rees (President 2024-2026) Dr H Gordon (President Elect 2024-2026) Dr S Al-Shamma (Secretary 2023-2025) Prof B Bhandari (Vice President Endoscopy 2024-2026) Prof A Dhar (Chair, Education Committee 2023-2025) Dr C Hollywood (Vice President Hepatology 2023-2025) Dr M Kurien (Chair, CSSC 2024-2026) Mrs S Linnington (CEO 2023-) Dr J Morris (Treasurer 2024-2026) Dr S Panter (Chair, Training Committee 2023-2025) Prof D Shawcross (Chair, Research Committee 2024-2026) Prof H Steed (Senior Secretary 2023-2025) Dr M Thoufeeq (Chair, International Committee 2023-2025)

The Council

The professional activities of the Society are overseen by a Council with delegated authority from the Board of Trustees. The Council has responsibility for advising the Board on all matters pertaining to professional practice and the reputation of the Society. All members of the Executive are voting members of Council.

Members of Council

Prof C Rees (President 2024-2026) Dr H Gordon (President Elect 2024-2026) Dr S Al-Shamma (Secretary 2023-2025) Dr U Basavaraju (Elected member 2022-2025) Prof P Bhandari (Vice President Endoscopy 2024-2026) Dr M Bose (QI Lead, CSSC 2024-2026) Dr M Cowan (Elected Member, 2023-2026) Prof A Dhar (Chair, Education Committee 2023-2025) Dr L Donnelly (BSG Nurses Association 2024-2027) Dr S Everett (Elected member, 2023-2026) Prof D Gaya (Elected member, 2022-2025) Dr R Gwenter (Chair, Trainee Section 2024-2025) Dr C Hollywood (Vice President Hepatology 2023-2025) Dr M Kurien (Chair, CSSC 2024-2026) Mrs S Linnington (CEO 2023-) Dr A Mukhopadhya (Elected member, 2023-2026) Dr J Morris (Treasurer 2024-2026) Dr M Nayar (Elected member 2022-2025) Dr S Panter (Chair, Training Committee 2023-2025) Dr P Phull (Guidelines Lead, CSSC 2022-2025) Dr S Samji (Workforce Lead 2022-January 2025) Prof S Sebastian (Elected member, 2024-2027)

British Society of Gastroenterology 18

Prof D Shawcross (Chair, Research Committee 2024-2026) Prof H Steed (Senior Secretary 2023-2025) Prof S Thomas-Gibson (Elected member, 2024-2027) Dr M Thoufeeq (Chair, International Committee 2023-2025)

Observer members

Mr J Davies (ACPGBI) Mr J Catton (AUGIS) Dr N Thompson (BAPEN) Dr T Cross (BASL) Dr K Lindley (BSPGHAN) Prof E El Omar (Editor, Gut) Dr P Smith (Editor, Frontline Gastroenterology) Dr C Selinger (Editor, BMJ Open Gastroenterology) Ms S Hudson (CEO, Guts UK) Dr M Sloan (PCSG) Dr O Griffin (PSGBI) Dr A Jawhari (Chair, SAC)

The business of Council is informed by ve higher committees and their sub-committees.

The Society is represented at regional level by regional leads within the CSSC. Separately there are sections for the academic and professional advancement of specialist interests. These sections are: Adolescents & Young Persons, Association of GI Physiology Professions, Colorectal, Endoscopy, Oesophageal, Pancreatobiliary, Pathology, Small Bowel & Nutrition, Supporting Women in Gastroenterology (SWiG) and Trainees. Section Chairs are represented on the Education (and Programme) Committee and Research Committee.

British Society of Gastroenterology 19

Operational

remained stable and in November 2024, a Society also maintains several contracts for specialist professional services, including HR, needs or support projects. Remuneration for key management personnel is set by benchmarking exercises, which are carried out by external HR Consultants. Annual performance reviews are carried out by employees' line managers, or in the case of the Chief Executive, by the President. Ultimate responsibility for lies with the President.

Fundraising

The charity does not actively solicit donations and therefore is not registered with the Fundraising Regulator and does not subscribe to any fundraising codes of practice. On occasion, when donations from individuals are received, the charity aims to protect personal data and never sells data or swaps data with other organisations.

Organisational Governance Achievements

Equality, Diversity and Inclusion

importance for everyone involved in our organisation. We welcome and actively seek to recruit

British Society of Gastroenterology 20

individuals to our activities regardless of race, religion, ethnic origin, disability, age, gender, sexual orientation or working pattern. The BSG aims to encourage diversity of membership in all committees,

The BSG not only seeks to promote equal opportunities for all our members but also actively tries to encourage members who might not immediately see themselves as potential contributors to the Society's work, to take on roles. We regard diversity as one of our greatest assets. To enable this:

representation and opportunity within gastroenterology and are committed to addressing these both inside and, where possible, outside the organisation. A comprehensive ED&I strategy was launched in 2023, and a working group monitors the progress of this strategy via key performance indicators and timelines which are performance managed at Executive level and reported at Board level.

A new website was launched in March 2024 to improve the member experience and enable the organisation to collect more ED&I data.

Risk Management

The Trustees of the Society have overall responsibility for risk management within the Society.

Key Risks and Mitigation

A review of the Society's formal risk register is a standing item at every meeting of Board of Trustees, which implements mitigations as and when required. The Risk Register is maintained by the operational team under the leadership of the CEO. The CEO holds overall responsibility for the oversight and maintenance of the risk register.

Financial

A Finance and Investment Committee (FIC), consisting of the BSG Treasurer, three of the Society's independent Trustees, the President, President-Elect, and the Chief Executive, reviews the nancial activities of the Society, including investment decisions, to mitigate the risk of loss of income and reports directly to the Board of Trustees.

Failure of Annual Meeting

The Annual Meeting is the main event in the BSG's calendar. As well as being a major source of revenue, it is key to maintaining and enhancing the reputation of the Society. The risk to the Society should the meeting be cancelled, go ahead without an optimal programme, or fail to attract to 2020.

British Society of Gastroenterology 21

The Society has prepared for such an event by assiduous planning. This is led by senior executive and careful project management through professional conference organisers. In addition, the BSG has, as part of its free reserves, £1,000,000 designated to cover expenses in the event of a meeting failing to take place or having to be curtailed.

Potential Reduction in Publishing Revenues

income. However, the nature of the publishing landscape is changing and an initiative called 'Plan S' is likely to have a material impact on this revenue stream in the future. Plan S is an initiative for open-access science publishing launched in 2018 by a consortium of national research agencies and funders from twelve European countries. The plan requires scientists and researchers who from state-funded research organisations and institutions to publish their work in open repositories or in journals that are available to all.

The Society has continued to work closely with BMJ publications. After discussion, it was agreed to make Gut and Frontline Gastroenterology hybrid journals, designating them as being "in transition" allowing them to continue to publish all types of material.

The future of Plan S is still not clear, and the situation is complicated by other long-term trends in publishing, such as a move away from paper to electronic copies. Some reduction in income seems probable over the coming ve years but the Society is aware and taking measures to minimise the impact. Meanwhile, income from BMJ has increased in 2024 partly due to lower production costs and an increase in open access fees.

Risk Mitigation, Guidelines, and Professional Advice

The Society never gives advice to individual members of the public. All its advice is generic. The Society publishes Guidelines and Professional advice. There is a risk that a company or individuals

Guidelines are developed by working groups of professionals usually including lay members of the public, using strict evidence-based criteria based on literature searches and the grading of evidence which are generally subject to external review and published in peer reviewed journals.

Financial report for the year

Results for the year

British Society of Gastroenterology

22

The profit within BSG Limited amounted to £207,034 (2023 - profit of £180,962).

Investment Policy and Performance

In May 2020, after a retender process, the Finance & Investment Committee awarded the management of the Society's investment portfolio to CCLA. The Society's investment strategy is medium risk. The policy takes account of ethical considerations such as restrictions on tobacco and alcohol-related investment. In addition, the Trustees agreed that whilst supporting companies (i.e. in funds). Details of the Society's investments are set out in note 12 to the nancial statements.

The Trustees consider the fund to have performed adequately during 2024 within the context of the economic environment but reserve the right to review and tender for alternative providers as part of an active approach to investment oversight.

Reserves and Going Concern Assessment

The Trustees continue to actively address the issue of reserves in the context of future plans and requirements of the Society. The cash needs of the Society are well within the assets it holds and the income it generates.

The objective is to maintain funds to support the key activities of the Society for one calendar year. This includes the annual meeting, 12 months' costs, and funds to discharge essential operating expenses, giving a total minimum required free reserve of approximately £1,600,000. The general funds, or free reserves, of the group at the year-end were £1,762,187 (2023 - £2,063,255) and this is broadly in line with the target set out above. The level of free reserves is regularly reviewed by Trustees.

Total funds of the charity at the year-end were £8,599,509 (2023 - £8,303,069). This included restricted funds of £100,114 (2023 - £122,042) and designated funds at the year-end totalled £6,737,208 (2023 - £6,117,772). Details of the designated funds are given in note 15 to the nancial statements.

There is a reasonable expectation that the BSG has adequate resources to continue in operational existence for the foreseeable future. The Trustees believe that there are no material uncertainties that call into doubt the Group and the Charity's ability to continue operating as a going concern. In making this decision, the Trustees have also taken into consideration the risks and conclude that the Group and the Charity can sustain their operations for a period of at least twelve months from statements have therefore been prepared on the basis that the Group and the Charity remain a going concern.

British Society of Gastroenterology 23

Statement of Trustees' responsibilities

The Trustees (who are also directors of the British Society of Gastroenterology for the purposes of accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

give a true and fair view of the state of the charitable company and the group and of the incoming resources and application of resources, including the income and expenditure, of the group for that period.

In preparing these nancial statements, the Trustees are required to:

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time

safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

information included on the charity's website. Legislation in the United Kingdom governing the jurisdictions.

Each of the Trustees that:

so far as the Trustee is aware, there is no relevant audit information of which the charitable company's auditor is unaware; and

the Trustee has taken all the steps that he/she ought to have taken as a Trustee in order to

British Society of Gastroenterology 24

make himself/herself aware of any relevant audit information and to establish that the charitable company's auditor is aware of that information.

This the Companies Act 2006.

Approved by the Trustees and signed on their behalf by:

Professor Colin Rees Chair of the BSG Board of Trustees

Approved by the Trustees on:

British Society of Gastroenterology 25

INDEPENDENT REPORT TO THE MEMBERS AND TRUSTEES OF BRITISH SOCIETY OF GASTROENTEROLOGY

Opinion

We have audited the Consolidated Statement of Financial Activities, the Consolidated and Parent Charitable Company Balance accounting policies. The nancial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 Financial Reporting Standard Applicable

In our opinion the nancial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable accordance with the ethical requirements that are relevant to our audit of the nancial statements in the UK, including the Ethical Standard, and we have our other ethical responsibilities in accordance with provide a basis for our opinion.

Conclusions relating to going concern

the going concern basis of

Based on the work we have performed, we have not any material uncertainties relating to events or company's ability to continue as a going concern for a period of at least twelve months from when the nancial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

statements and our report thereon. The trustees are responsible for the other information contained except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is

British Society of Gastroenterology 26

otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to

statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and parent charitable company and their environment obtained in the course of the audit, we have not material misstatements in the annual report.

We have nothing to report in respect of the following matters where the Companies Act 2006 and the Charities Act 2011 require us to report to you if, in our opinion:

Responsibilities of trustees

misstatement, whether due to fraud or error.

are responsible for assessing the group and parent charitable and using the going concern basis of accounting unless the trustees either intend to liquidate the group or parent charitable company or to cease operations, or have no realistic alternative but to do so.

Responsibilities for the audit of the nancial statements

We have been appointed as auditor under the Companies Act 2006 and section 151 of the Charities Act 2011 and report in accordance with those Acts.

Our objectives are to obtain reasonable assurance about whether the nancial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in

British Society of Gastroenterology 27

accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in aggregate, they could reasonably be

As part of an audit in accordance with ISAs (UK) we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

We communicate with those charged with governance regarding, among other matters, the planned scope and we identify during our audit.

Explanation as to what extent the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

The objectives of our audit in respect of fraud, are; to identify and assess the risks of material misstatement of risks of material misstatement due to fraud, through designing and implementing appropriate responses to

British Society of Gastroenterology 28

the audit. However, the primary responsibility for the prevention and detection of fraud rests with both management and those charged with governance of the charitable company.

Our approach was as follows:

There are inherent limitations in the audit procedures described above. We are less likely to become aware of instances of non-compliance with laws and regulations that are not closely related to events and transactions higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

Use of our report

trustees, as a body, in accordance with Chapter 3 of Part 8 of the Charities Act 2011. Our audit work has been undertaken so that we might state to the charitable members and trustees those matters which we by law, we do not accept or assume responsibility to any party other than the charitable company, the report, or for the opinion we have formed.

Adam Fullerton (Senior Statutory Auditor)

for and on behalf of Moore Kingston Smith LLP, Statutory Auditor

6[th] Floor

9 Appold Street

London

Date: 10 July 2025

EC2A 2AP

Moore Kingston Smith LLP is eligible to act as auditor in terms of Section 1212 of the Companies Act 2006.

British Society of Gastroenterology 29

Consolidated statement of nancial activities Year to 31 December 2024 (incorporating income and expenditure)

Notes Unrestricted
£		 Restricted
£		 2024
Total funds
£		 Unrestricted
£		 Restricted
£		 2023
Total funds
£
Income
Donations and legacies:
Membership subscription
1
Investment income
2
Other
Charitable activities:
3
Education and training
GI research
Total income
Expenditure
Cost of raising funds
4
Cost of charitable activities :
5
Education and training
GI research
Service standards
International
Total expenditure
Net income/(expenditure) before
gains/(losses) on investments
8
Gains/(losses) on investments
12
Unrealised gains on investments
Net income/(expenditure) and net
movement in funds for the year
Reconciliation of funds
Fund balances brought forward at 1
January
Fund balances carried forward at 31
December		 566,550
236,353
70,409
2,114,268
881,441		 -
-
-
22,210
-		 566,550
236,353
70,409
2,136,478
881,441		 547,248
224,194
72,038
1,917,613
729,662		 -
-
-
24,800
-		 547,248
224,194
72,038
1,942,413
729,662
3,869,021 22,210 3,891,231 3,490,755 24,800 3,515,555
103,958
2,604,467
631,858
272,830
143,369		 -
16,171
3,682
24,285
-		 103,958
2,620,638
635,540
297,115
143,369		 104,609
2,458,731
614,140
343,971
118,124		 -
16,711
-
6,744
-		 104,609
2,475,442
614,140
350,715
118,124
3,756,482 44,138 3,800,620 3,639,575 23,455 3,663,030
112,539
205,829		 (21,928)
-		 90,611
205,829		 (148,820)
647,911		 1,345
-		 (147,475)
647,911
205,829
318,368
8,181,027		 -
(21,928)
122,042		 205,829
296,440
8,303,069		 499,091
7,681,936		 1,345
120,697		 500,436
7,802,633
8,499,395 100,114 8,599,509 8,181,027 122,042 8,303,069

All of the activities derived from continuing operations during the above nancial year.

British Society of Gastroenterology 30

Balance Sheet 31 December 2024

Group Group Charity
Notes 2024
£
38,888
7,653,549
7,692,437
880,679
488,775
1,369,454
(462,382)
907,072
8,599,509		 2023
£		 2024
£
2023
£
38,888
34,379
7,653,550
7,447,721
7,692,438
7,482,100
844,416
745,776
332,223
330,297
1,176,639
1,076,073
(269,568)
(255,104)
907,071
820,969
8,599,509
8,303,069
Fixed assets
Tangible assets
11
Investments
12
Current assets
Debtors
13
Cash at bank and in hand
Liabilities:
Creditors: amounts falling due
within one year
14
Net current assets
Total net assets
The funds of the charity:
Unrestricted funds:
General funds
Designated funds
15
Restricted funds
16
17		 34,379
7,447,720
7,482,099
804,143
461,763
1,265,906
(444,936)
820,970
8,303,069
1,762,187
6,737,208
100,114
8,599,509		 2,063,255
6,117,772
122,042		 1,762,187
2,063,255
6,737,208
6,117,772
100,114
122,042
8,599,509
8,303,069
8,303,069

The consolidated nancial statements of the group incorporate the nancial statements of the Society and the trading are not represented for the charity itself following the exemption by section 408 of the Companies Act 2006. The net income of the charity for the year was £296,440 (2023: £500,436).

Approved by the Trustees and signed on their behalf by:

Professor Colin Rees

Chair of the BSG Board of Trustees

Approved on: 22 June 2025

British Society of Gastroenterology

Registered Company Number: 08124892 (England and Wales)

British Society of Gastroenterology 31

Statement of cash ows Year to 31 December 2024

Notes 2024
£		 2023
£
Cash
ow from operating activities:
Net cash (used in) provided by operating activities
A
Cash
ow from investing activities:
Dividends and interest from investments
Purchase of tangible
xed assets
Net cash provided by investing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at 1 January
B
Cash and cash equivalents at 31 December
B		 (190,962) (570,055)
236,353
(18,379)		 224,194
(3,120)
217,974 221,074
27,012
461,763		 (348,981)
810,744
488,775 461,763

Notes to the statement of cash ows for the year to 31 December

A Reconciliation of net movement in funds to net cash ow from operating activities

Reconciliation of net movement in funds to net cash
ow from operating activities
2024
£		 2023
£
Net movement in funds (as per the statement of
nancial activities)
Adjustments for:
Depreciation charge
Amortisation
(Gains)/losses on investments
Dividends and interest from investments
on disposal of tangible
xed assets
Increase in debtors
Increase in creditors
Net cash(used in) provided by operating activities		 296,440
13,870
-
(205,829)
(236,353)
-
(76,536)
17,446		 500,436
13,489
12,619
(647,911)
(224,194)
12,943
(318,351)
80,914
(190,962) (570,055)

B Analysis of changes in net debt

Cash at bank and in hand
Total cash and cash equivalents		 1 January
2024
£
Movement
in year
£		 31 December
2024
£
461,763
27,012		 488,775
461,763
27,012		 488,775

British Society of Gastroenterology 32

Principal accounting policies Year to 31 December 2024

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation

Basis of preparation

These nancial statements have been prepared for the year to 31 December 2024, with comparative information for the year to 31 December 2023, and are presented in sterling and rounded to the nearest pound.

statements.

The nancial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (Charities SORP FRS 102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The charity constitutes a public entity as by FRS 102.

Critical accounting estimates and areas of judgement

Preparation of the nancial statements requires the Trustees and management to make judgements and estimates.

The items in the nancial statements where these judgements and estimates have been made include:

Assessment of going concern

The Trustees have assessed whether the use of the going concern assumption is appropriate in preparing these nancial statements. The Trustees have made this assessment in respect to a period of one year from the date of

The Trustees of the charity have concluded that there are no material uncertainties related to events or conditions that may cast significant doubt on the ability of the group and the charity to continue as a going concern. They are of the opinion that the group and the charity will have sufficient resources to meet its liabilities as they fall due. The Trustees do not have material concerns regarding the group and the ability to continue as a going concern.

With regard to the next accounting period, the year ending 31 December 2025, the most significant areas that affect the carrying value of the assets held by the charity are the level of investment return and the performance of the investment markets.

Basis of consolidation

The consolidated financial statements of the group incorporate the financial statements of the Society and the trading subsidiary it controls, BSG Limited. These have been consolidated on a line by line basis. A separate statement of financial activities and income and expenditure account are not represented for the charity itself following the exemption afforded by section 408 of the Companies Act 2006.

British Society of Gastroenterology 33

Income recognition:

Income is recognised in the period in which the group and the charity have entitlement to the income, the amount of income can be measured reliably, and it is probable that the income will be received.

Subscription income

Subscription income is accounted for in the financial period for which it is due.

Publication income

The Society has a contract with BMJ Publications for the publication of the journals, which gives 50% of any surplus on a quarterly basis to the Society. The Society also receives advertising income from the publications, via BSG Limited. All publication income is accounted for on a receivable basis.

meetings

The income arising from scientific meetings is recognised on a receivable basis.

Donations

Donations are credited to the statement of financial activities in the year in which they are received.

Investment income

Dividends are recognised once the dividend has been declared and notification has been received of the dividend due.

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the bank.

Expenditure recognition

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the group and the charity to make a payment to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis. Expenditure comprises direct costs and support costs. All expenses, including support costs, are allocated or apportioned to the applicable expenditure headings. The classification between activities is as follows:

Expenditure is stated net of VAT and irrecoverable VAT is included in support costs.

British Society of Gastroenterology 34

Allocation of support and governance costs

Support costs represent indirect charitable expenditure. In order to carry out the primary purposes of the charity it is necessary to provide support in the form of financial procedures, provision of office services and equipment and a suitable working environment.

Governance costs comprise the costs directly attributable to the governance of the charity, including audit costs and the necessary legal procedures for compliance with statutory requirements.

Support costs and governance costs are allocated between activities with the allocation based on staff time use.

Pension costs

The charity operates a defined contribution scheme on behalf of its employees. The assets are held in separately administered funds. Costs are charged to the statement of financial activities in the period to which they relate.

Tangible xed assets

Depreciation is provided at the following annual rates in order to write off the cost of each asset over its estimated useful life:

Office furniture, fittings and equipment - 5 years
Leasehold building - 25 years

Items used in the day to day running of the Society and with a cost in excess of £500 are capitalised, and are stated at cost less accumulated depreciation.

Debtors

Debtors are recognised at their settlement amount, less any provision for non-recoverability. Prepayments are valued at the amount prepaid.

Cash at bank and in hand

Cash at bank and in hand represents such financial statements and instruments that are available on demand or have a maturity of less than three months from the date of acquisition.

Creditors and provisions

Creditors and provisions are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Creditors and provisions are recognised at the amount the group and the charity anticipates it will pay to settle the debt.

British Society of Gastroenterology 35

Fund structure

The Society has various types of funds for which it is responsible, and which require separate disclosure. These are as follows:

General funds

Funds which are expendable at the discretion of the Trustees in furtherance of the objects of the Society.

Designated funds

Funds which are set aside as part of the unrestricted funds for particular purposes in the future.

Restricted funds

Funds raised for, and their use restricted to, a specific purpose, or donations subject to donor imposed conditions.

Investments

Listed investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price.

The charity does not acquire put options, derivatives or other complex financial instruments.

Realised gains (or losses) on investment assets are calculated as the difference between disposal proceeds and their opening carrying value or their purchase value if acquired subsequent to the first day of the financial year. Unrealised gains and losses are calculated as the difference between the fair value at the year end and their carrying value at that date. Realised and unrealised investment gains (or losses) are combined in the statement of financial activities and are credited (or debited) in the year in which they arise.

Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks and other short term liquid investments with original maturities of three months or less.

Financial instruments

The charity only holds basic financial instruments as defined in FRS 102. The financial assets and financial liabilities of the charity and their measurement basis are as follows:

Financial assets other debtors are basic financial instruments and are debt instruments measured at amortised cost. Listed investments are a basic financial instrument as detailed above. Prepayments are not financial instruments.

Cash at bank classified as a basic financial instrument and is measured at face value.

Financial liabilities accruals and other creditors are financial instruments, and are measured at amortised cost.

Taxation

The Society is a registered charity and therefore is not liable for income tax or corporation tax on income derived from its charitable activities, as it falls within the various exemptions available to registered charities.

British Society of Gastroenterology 36

Notes to the nancial statements Year to 31 December 2024

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation

1. Subscriptions

Subscriptions
Unrestricted funds
2024
£
2023
£
Membership subscriptions
Total funds		 566,550
547,248
566,550
547,248

2. Investment income

Investment income
Unrestricted funds
2024
£
2023
£
Income from listed investments
Interest receivable
Total funds		 217,064
210,209
19,289
13,985
236,353
224,194

3. Income from charitable activities

Unrestricted
£		 Restricted
£		 2024
Total funds
£		 Unrestricted
£		 Restricted
£		 2023
Total funds
£
Education and training
. Annual Conference and Campus
. Trainee events and meetings
. Other education events
. Sponsorship income
. Other income
GI Research
.
Frontline Gastroenterology
and Open Gastro journals
Total funds		 2,007,735
50,083
40,800
15,650
-		 -
-
18,000
-
4,210		 2,007,735
50,083
58,800
15,650
4,210		 1,753,398
71,579
35,204
57,432
-		 -
-
20,000
-
4,800		 1,753,398
71,579
55,204
57,432
4,800
2,114,268 22,210 2,136,478 1,917,613 24,800 1,942,413
881,441 - 881,441 729,662 - 729,662
881,441 - 881,441 729,662 - 729,662
2,995,709 22,210 3,017,919 2,647,275 24,800 2,672,075

4. Cost of raising funds

Cost of raising funds
Unrestricted funds
2024
£
2023
£
Staff costs (note 9)
Total funds		 103,958
104,609
103,958
104,609

British Society of Gastroenterology

37

5. Expenditure on charitable activities

Unrestricted
£		 Restricted
£		 2024
Total funds
£		 Unrestricted
£		 Restricted
£		 2023
Total funds
£
Education and training
Direct costs:
Annual Conference and Campus
Trainee events and meetings
Section and Committee events and
meetings
Other conferences and events
Project 90
Mentoring
Staff costs (note 9)
Bursaries and Prizes
Support costs (note 6)
GI Research
Direct costs:
journal
Frontline Gastroenterology
journal
Open Gastroenterology journal
Research events and meetings
Bursaries and prizes
Clinical Research Groups
Priority setting partnerships
Research projects
Staff costs (note 9)
Grant to Guts UK
Support costs (note 6)
Service standards
Direct costs:
Guidelines
Meeting and other costs
Staff costs (note 9)
Support costs (note 6)
International
Direct costs:
Staff costs (note 9)
Other costs
Grants and awards
Support costs (note 6)
Total funds		 1,658,858
88,346
143,210
-
4,448
5,723
206,233
27,561
470,088		 -
-
16,171
-
-
-
-
-
-		 1,658,858
88,346
159,381
-
4,448
5,723
206,233
27,561
470,088		 1,463,546
91,298
154,622
8,446
-
5,902
189,956
22,056
522,905		 -
-
11,573
-
-
-
-
3,476
1,662		 1,463,546
91,298
166,195
8,446
-
5,902
189,956
25,532
524,567
2,604,467 16,171 2,620,638 2,458,731 16,711 2,475,442
245,000
120,000
-
5,017
19,975
7,365
40,360
30,660
48,185
4,878
110,418		 -
-
-
3,682
-
-
-
-
-
-
-		 245,000
120,000
-
8,699
19,975
7,365
40,360
30,660
48,185
4,878
110,418		 262,967
94,780
397
23,473
4,382
2,001
4,827
2,500
54,899
12,312
151,602		 -
-
-
-
-
-
-
-
-
-
-		 262,967
94,780
397
23,473
4,382
2,001
4,827
2,500
54,899
12,312
151,602
631,858 3,682 635,540 614,140 - 614,140
22,667
19,211
72,216
158,736		 15,885
-
500
7,900		 38,552
19,211
72,716
166,636		 74,245
18,097
66,529
185,100		 6,244
-
500
-		 80,489
18,097
67,029
185,100
272,830 24,285 297,115 343,971 6,744 350,715
34,260
5,469
25,129
78,511		 -
-
-
-		 34,260
5,469
25,129
78,511		 26,381
-
18,892
72,851		 -
-
-
-		 26,381
-
18,892
72,851
143,369 - 143,369 118,124 - 118,124
3,652,524 44,138 3,696,662 3,534,966 23,455 3,558,421

British Society of Gastroenterology 38

6. Support costs

6. Support costs
Education
and
training
£		 GI
research
£		 Service
standards
£		 International
£		 2024
Total
£
Premises expenses
Administration and office expenses
Website
Legal and professional fees
Human Resources
Consultancy
Accountancy and bookkeeping
Staff costs
Recruitment and training
Marketing
Bank charges and foreign currency (gain)
Depreciation and disposal of assets
Sundry expenses
Irrecoverable VAT
Governance costs (note 7)
2024 Total		 49,892
73,409
48,992
12,421
6,758
29,163
20,367
134,981
19,036
17,147
2,715
7,897
8,158
15,547
23,605		 11,719
17,243
11,508
2,917
1,587
6,850
4,784
31,706
4,471
4,028
638
1,855
1,916
3,652
5,544		 17,686
26,022
17,366
4,403
2,395
10,338
7,220
47,848
6,748
6,078
962
2,799
2,892
5,511
8,368		 8,333
12,260
8,182
2,074
1,129
4,871
3,402
22,543
3,179
2,863
454
1,319
1363
2,596
3,943		 87,630
128,934
86,048
21,815
11,869
51,222
35,773
237,078
33,434
30,116
4,769
13,870
14,329
27,306
41,460
470,088 110,418 166,636 78,511 825,653
Education
and
training
£		 GI
research
£		 Service
standards
£		 International
£		 2023
Total
£
Premises expenses
Administration and office expenses
Website
Legal and professional fees
Human Resources
Consultancy
Accountancy and bookkeeping
Staff costs
Recruitment and training
Marketing
Bank charges and foreign currency (gain)
Depreciation and disposal of assets
Sundry expenses
Irrecoverable VAT
Governance costs (note 7)
2023 Total		 48,848
66,744
84,622
18,307
9,288
23,687
16,041
138,840
6,551
25,175
2,011
21,929
6,693
31,723
24,108		 14,118
19,289
24,456
5,290
2,685
6,846
4,636
40,126
1,893
7,276
581
6,338
1,934
9,168
6,966		 17,237
23,551
29,860
6,459
3,278
8,358
5,660
48,992
2,312
8,883
710
7,738
2,362
11,194
8,506		 6,784
9,269
11,752
2,542
1,290
3,290
2,228
19,282
910
3,496
279
3,046
930
4,406
3,347		 86,987
118,853
150,690
32,598
16,541
42,181
28,565
247,240
11,666
44,830
3,581
39,051
11,919
56,491
42,927
524,567 151,602 185,100 72,851 934,120

British Society of Gastroenterology 39

7. Governance

Governance
Unrestricted funds
2024
£
2023
£
Council meetings
meetings
remuneration
Total funds		 7,990
23,430
9,970
3,747
23,500
15,750
41,460
42,927

None of the Trustees received remuneration from the charity in respect of their services as Trustees (2023 - none).

8. Net income before gains/(losses) on investments

This is stated after charging:

Net income before gains/(losses) on investments
This is stated after charging:
Unrestricted funds
2024 2023
£ £
Staff costs (note 9) 753,652 732,297
Depreciation (note 11) 13,870 26,108
Loss on disposal of tangible fixed assets - 12,943
remuneration
Audit fees
current year		 23,500 15,750
Non-audit services - -

9. costs, remuneration of key management and

remuneration

Unrestricted funds
2024
£
2023
£
Wages and salaries
Social security cost
Pension cost
Consultancy costs		 584,030
561,483
54,234
50,571
42,309
43,102
680,573
655,156
73,079
77,141
753,652
732,297

costs analysed by activities:

costs analysed by activities:
Unrestricted funds
2024
£
2023
£
Cost of raising funds
Charitable activities:
Education and training
GI research
Service standards
International
Support costs		 103,958
104,611
206,233
189,956
48,185
54,899
72,716
67,029
34,260
26,381
288,300
289,421
753,652
732,297

British Society of Gastroenterology

40

The average number of employees, excluding agency and self-employed consultant staff, during the year was:

2024 2023
No. No.
Employees 12.3 12.9

The number of employees who earned £60,000 or more per annum (including taxable benefits but excluding employer pension contributions) during the period was as follows:

2024
No		 2023
No
£60,000 - £70,000
£80,001 - £90,000
£90,000-£100,000		 2
-
1		 1
1
-

Pension contributions for these employees totalled £14,491 (2023 10,444).

The key management personnel of the charity in charge of directing and controlling, running and operating the charity on a day to day basis comprise the Trustees, the Chief Executive, the Head of Marketing & communications, the Head of Committee Services and the Head of Digital. The total remuneration (including taxable benefits and employer's pension contributions) of the key management personnel for the year was £328,494 (2023 £308,012). No Trustee received any remuneration from the Society in their ongoing role as a Trustee. Travelling and subsistence expenses were reimbursed to eleven Trustees amounting to a total of £11,421 (2023 - £8,383 to 12 Trustees). At the year end a balance of £nil (2023 £nil) was owed to Trustees.

10.Net income from subsidiaries

The Society has one wholly-owned subsidiary, BSG Limited, which is incorporated in England and Wales (Company Registration Number 03021266). BSG Limited conducts scientific meetings on behalf of the Society. A

2024
£
2023
£
Turnover
Cost of sales
Gross profit
Administration
Interest receivable
Net profit (loss)
Gift Aid to BSG
Profit/(loss)for theperiod		 2,077,989
1,870,852
(1,834,622)
(1,653,093)
243,367
217,759
(39,823)
(40,727)
3,490
3,930
207,034
180,962
(207,034)
(180,962)
-
-

British Society of Gastroenterology 41

11. Fixed Assets

Tangible Fixed Assets

Tangible Fixed Assets
Group and charity Office
equipment,
fixtures and
fittings
£
Cost
At 1 January 2024
Additions
Disposals
At 31 December 2024
Depreciation
At 1 January 2024
Charge for the year
Eliminated on disposal
At 31 December 2024
Net book values
At 31 December 2024
At 31 December 2023		 65,181
18,379
(3,173)
80,387
30,802
13,870
(3,173)
41,499
38,888
34,379

12.Investments

2024
£
2023
£
Market value at 1 January
Additions at cost
Disposals at opening market value
Unrealised gains/(losses)
Market value at 31 December -Group
Investment in BSG Limited
Society		 7,447,720
6,799,809
-
-
-
-
205,829
647,911
7,653,549
7,447,720
1
1
7,653,550
7,447,721

At 31 December, the Group and listed investments comprised the following:

2024
£
2023
£
Unit funds (COIF Charity Fund)
Historical cost of investments		 7,653,549
7,447,720
7,653,549
7,447,720
6,557,113
6,557,113

British Society of Gastroenterology 42

The total unrealised gains as at 31 December constitutes movements on revaluation and are as follows:

2024
£
2023
£
Unrealised gains included above:
On investments
Total unrealised gains at 31 December
Reconciliation of movements in unrealised gains
Unrealised gains at 1 January
In respect to disposals in the year
Net gains arising on revaluation arising in the year
Total unrealisedgains at 31 December		 1,096,436
890,607
1,096,436
890,607
890,607
242,696
-
-
890,607
242,696
205,829
647,911
1,096,436
890,607

13. Debtors

13. Debtors
Group Charity
2024
£
23,750
70,542
125
-
-
786,262
880,679		 2023
£		 2024
£
2023
£
23,750
52,704
17,586
4,012
125
-
228,502
201,963
150,000
150,000
424,453
337,097
844,416
745,776
Trade debtors
VAT
Other debtors
Amounts due from subsidiary
Loan to subsidiary
Prepayments and accrued income		 52,704
24,597
-
-
-
726,842
804,143

Included within the above is a prepayment of £38,360 (2023: £38,360) relating to a deposit paid for venue hire in 2028 which is therefore a debtor balance falling due in over one year.

14.Creditors

14.Creditors
Group Charity
2024
£
247,328
197,142
17,162
750
462,382		 2023
£		 2024
£
2023
£
155,295
156,007
97,111
85,262
17,162
13,825
-
10
269,568
255,104
Trade creditors
Accruals and deferred income
Social Security and other taxation
Other creditors		 156,434
273,917
13,825
760
444,936

British Society of Gastroenterology 43

Included within the above is deferred income as set out below:

Group Charity
2024
£
68,300
44,825
(68,300)
44,825		 2023
£		 2024
£
2023
£
46,800
22,520
44,825
46,800
(46,800)
(22,520)
44,825
46,800
Deferred income brought forward at 1 January
Additional income deferred during the year
Brought forward funds released in the year
Deferred income carried forward at 31 December		 45,907
68,300
(45,907)
68,300

15.Designated funds

At 1 January
2024
£		 New
designations/
transfers
£		 Unrealised
gains
£		 Utilised in
year
£		 At 31
December
2024
£
Clinical projects
Membership development
Project 90
Investments
Investment unrealised gains
Tangible fixed assets		 1,100,394
92,392
-
4,000,000
890,607
34,379		 56,504
-
579,000
-
-
18,379		 -
-
-
-
205,829
-		 (158,860)
(55,090)
(12,456)
-
-
(13,870)		 998,038
37,302
566,544
4,000,000
1,096,436
38,888
6,117,772 653,883 205,829 (240,276) 6,737,208
At 1 January
2023
£		 New
designations/
transfers
£		 Unrealised
gains
£		 Utilised in
year
£		 At 31
December
2023
£
Clinical projects
Membership development
Investments
Investment unrealised gains
Tangible fixed assets		 1,221,077
129,934
4,000,000
242,696
70,310		 32,637
100,000
-
-
3,120		 -
-
-
647,911
-		 (153,320)
(137,542)
-
-
(39,051)		 1,100,394
92,392
4,000,000
890,607
34,379
5,664,017 135,757 647,911 (329,913) 6,117,772

Clinical Projects

Amount have been designated for various projects including:

Research : An amount has been designated for research grants.

Research PSP: Funds have been set aside as part of the Research strategy over the next 3 years, the BSG will be cofunding the development of various PSP (Priority Setting Partnerships). All requests for funding are submitted to the Research Committee for approval.

British Society of Gastroenterology 44

Workforce App: A sum of money has been designated for the development of a Workforce app to support the membership.

Membership development

This has been designated for membership development.

Investments

The Society considers the income from their investment portfolio to subsidise the general operations of the charity. Holding the investment portfolio helps to mitigate the risk of cyclical reductions in other income streams. The Society has determined that a minimum of £4,000,000 should be designated as an investment fund to ensure an ongoing level of supplementary income sufficient to contribute towards the cost base of the Society can be generated in perpetuity.

Investment gains

The Society has also designated the unrealised gains from investment holdings as it is not the intention to draw down on these amounts in the short term.

Tangible and intangible assets

This fund represents the net book value of the tangible and intangible assets of the Society.

16.Restricted funds

16.Restricted funds
At 1 January
2024
£		 Income
£		 Expenditure
£		 At 31
December
2024
£
Endoscopy - Paul Brown travel fund
Presidents travel fund
Pathologists Group fund
Barretts Oesophagus Registry
KSS Lewisham
Section funds
. IBD Section
. Clinical Measurement
. NGM
Other		 3,540
828
2,603
79,990
11,594
1,300
15,585
2,920
3,682		 -
-
-
-
18,000
-
4,210
-
-		 -
-
(1,926)
(3,735)
(24,285)
(1,300)
(6,629)
(2,581)
(3,682)		 3,540
828
677
76,255
5,309
-
13,166
339
-
122,042 22,210 (44,138) 100,114

British Society of Gastroenterology 45

At 1 January
2023
£		 Income
£		 Expenditure
£		 At 31
December
2023
£
Endoscopy - Paul Brown travel fund
Presidents travel fund
Pathologists Group fund
Barretts Oesophagus Registry
Galapagos Travel Bursary
KSS Lewisham
Section funds
. Oesophageal Section
. IBD Section
. Clinical Measurement
. NGM
. SWiG
Other		 3,540
828
2,603
82,079
3,476
-
2,850
1,300
15,755
3,627
957
3,682		 -
-
-
-
-
20,000
-
-
4,800
-
-
-		 -
-
-
(2,089)
(3,476)
(8,406)
(2,850)
-
(4,970)
(707)
(957)
-		 3,540
828
2,603
79,990
-
11,594
-
1,300
15,585
2,920
-
3,682
120,697 24,800 (23,455) 122,042

Restricted funds are as follows:

The Paul Brown travel fund represents a donation received from Keymed for small travel grants to UK doctors to visit Endoscopy Centres abroad to enable them to learn specific techniques.

The presidents travel fund represents donations received to be utilised on travel expenses for the BSG president.

The Pathologists Group fund is a donation to support the annual Basil Morson Lecture.

The Barretts Oesophagus Registry is a donation from the Barretts Oesophagus Registry to fund Trainees to attend DDW.

The Section funds represent the income and expenditure in relation to the activities of these sections of the Society.

17.Analysis of net assets between funds

Unrestricted funds Unrestricted funds Restricted
funds
£		 Total
funds
£
General
fund
£		 Designated
funds
£
Fund balances at 31 December 2024 are represented
by:
Tangible fixed assets
Investments
Current assets
Current liabilities		 -
2,557,113
(374,906)
(420,020)		 38,888
5,096,436
1,628,246
(26,362)		 -
-
116,114
(16,000)		 38,888
7,653,549
1,369,454
(462,382)
1,762,187 6,737,208 100,114 8,599,509

British Society of Gastroenterology 46

Unrestricted funds
General
fund
£
Designated
funds
£
-
34,379
2,557,113
4,890,607
(122,249)
1,244,057
(371,609)
(51,271)
2,063,255
6,117,772		 Restricted
funds
£		 Total
funds
£
Fund balances at 31 December 2023 are represented
by:
Tangible fixed assets
Investments
Current assets
Current liabilities		 -
2,557,113
(122,249)
(371,609)
2,063,255		 -
144,098
(22,056)		 34,379
7,447,720
1,265,906
(444,936)
122,042 8,303,069

18. Ultimate control and related party transactions

The charity has no ultimate controlling party

No Trustee received remuneration from the group and charity in respect of their services as Trustee.

19. Guts UK Charity

The Society works closely with Guts UK Charity (previously known as Core The Digestive Disorders Foundation) (Charity Registration No 1137029 and Company Registration No 07274105 (England and Wales)) to support Guts practice and the provision of patient information to the public; Guts UK is the only charity dedicated to the whole of gastrointestinal diseases. The Chairman of the Research Committee of the BSG is a Trustee of Guts UK. The President of Guts UK is an ex-officio member of the BSG Council.

Transactions between the two charities during the year were as follows: The Society gave one grant of £4,878 to Guts UK during the year (2023 one grant of £12,312).

20. Financial commitments

order to secure bookings for future Annual Conferences the subsidiary company BSG Limited has entered into venue hire contracts for 2024 through to 2028. Under these contracts the company is committed to paying venue hire costs of £138,197 within the next 12 months and £736,397 in 2 to 5 years.

British Society of Gastroenterology 47